Precigen to announce fourth quarter and full year 2023 financial results on march 19th

Germantown, md. , march 5, 2024 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the company will report fourth quarter and full year 2023 financial results on tuesday, march 19, 2024.
PGEN Ratings Summary
PGEN Quant Ranking